DNA Insider Trading Activity and SEC Form 4 Filings
DNA insider trading summary
Over the past 12 months, insiders at Ginkgo Bioworks Holdings, Inc. (DNA) reported 23 sales worth $5.0M by 5 insiders and no open-market purchases on SEC Form 4. Net insider selling was $5.0M.
Latest DNA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Steven P. Coen | See remarks | Sell | $8K (766 @ $10.14) |
| Oct 19, 2026 | Reshma P. Shetty | See remarks | Sell | $191K (18,803 @ $10.14) |
| Oct 19, 2026 | Reshma P. Shetty | See remarks | Sell | $227K (22,369 @ $10.14) |
| Oct 19, 2026 | Barry Canton | 10% Owner | Sell | $191K (18,803 @ $10.14) |
| Oct 19, 2026 | Jason R Kelly | See remarks | Sell | $463K (45,682 @ $10.14) |
| Oct 19, 2026 | Barry Canton | 10% Owner | Sell | $227K (22,369 @ $10.14) |
| Oct 5, 2026 | Steven P. Coen | See remarks | Sell | $36K (2,403 @ $15.00) |
| Sep 15, 2026 | Christian O Henry | Director | Sell | $35K (5,000 @ $7.08) |
| Aug 24, 2026 | Steven P. Coen | See remarks | Sell | $2K (330 @ $6.98) |
| Jul 17, 2026 | Steven P. Coen | See remarks | Sell | $6K (752 @ $7.90) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.